{"name":"Allozyne","permalink":"allozyne","crunchbase_url":"http://www.crunchbase.com/company/allozyne","homepage_url":"http://www.allozyne.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":2005,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@allozyne.com","phone_number":"206-518-5700","description":"","created_at":"Fri Mar 12 04:04:05 UTC 2010","updated_at":"Tue Aug 31 11:48:34 UTC 2010","overview":"<p>Allozyne develops and commercializes technologies that enable improvements in the efficacy, safety, dosing, and other characteristics of protein-based therapeutics, including peptides, antibodies, and vaccines. Its PEGylated IFN beta is for the treatment of multiple sclerosis. The company was founded in 2005 and is based in Seattle, Washington.</p>","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$33.5M","funding_rounds":[{"round_code":"b","source_url":"http://www.allbusiness.com/company-activities-management/board-management-changes/5299825-1.html","source_description":"Allozyne, Inc., Closes $30 Million Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":26,"investments":[{"company":null,"financial_org":{"name":"MPM Capital","permalink":"mpm-capital","image":{"available_sizes":[[[150,142],"assets/images/resized/0004/5561/45561v1-max-150x150.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-250x250.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"OVP Venture Partners","permalink":"ovp-venture-partners","image":{"available_sizes":[[[150,63],"assets/images/resized/0003/0402/30402v1-max-150x150.png"],[[250,106],"assets/images/resized/0003/0402/30402v1-max-250x250.png"],[[272,116],"assets/images/resized/0003/0402/30402v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Amgen Ventures","permalink":"amgen-ventures","image":null},"person":null},{"company":null,"financial_org":{"name":"ARCH Venture Partners","permalink":"arch-venture-partners","image":{"available_sizes":[[[131,71],"assets/images/resized/0003/6165/36165v1-max-150x150.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-250x250.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Alexandria Real Estate Equities","permalink":"alexandria-real-estate-equities","image":{"available_sizes":[[[150,52],"assets/images/resized/0005/2582/52582v2-max-150x150.jpg"],[[235,82],"assets/images/resized/0005/2582/52582v2-max-250x250.jpg"],[[235,82],"assets/images/resized/0005/2582/52582v2-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"a","source_url":"http://www.goodwinprocter.com/News-and-Events/Press-Releases/2005/Allozyne-Inc-Raises-35-Million-in-Series-A-Funding.aspx","source_description":"Allozyne Inc. Raises $3.5 Million in Series A Funding","raised_amount":3500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":6,"investments":[{"company":null,"financial_org":{"name":"MPM Capital","permalink":"mpm-capital","image":{"available_sizes":[[[150,142],"assets/images/resized/0004/5561/45561v1-max-150x150.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-250x250.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"ARCH Venture Partners","permalink":"arch-venture-partners","image":{"available_sizes":[[[131,71],"assets/images/resized/0003/6165/36165v1-max-150x150.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-250x250.png"],[[131,71],"assets/images/resized/0003/6165/36165v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"OVP Venture Partners","permalink":"ovp-venture-partners","image":{"available_sizes":[[[150,63],"assets/images/resized/0003/0402/30402v1-max-150x150.png"],[[250,106],"assets/images/resized/0003/0402/30402v1-max-250x250.png"],[[272,116],"assets/images/resized/0003/0402/30402v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Amgen Ventures","permalink":"amgen-ventures","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"1600 Fairview Ave E.","address2":"Suite 300","zip_code":"98102","city":"Seattle","state_code":"WA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}